Long-term Study of Romiplostim in Thrombocytopenic Pediatric Patients With Immune Thrombocytopenia (ITP)

PHASE3CompletedINTERVENTIONAL
Enrollment

203

Participants

Timeline

Start Date

December 10, 2014

Primary Completion Date

August 30, 2018

Study Completion Date

August 8, 2019

Conditions
Immune Thrombocytopenia
Interventions
DRUG

Romiplostim

Romiplostim subcutaneous weekly injection

Trial Locations (78)

1020

Research Site, Brussels

1094

Research Site, Budapest

1200

Research Site, Brussels

2013

Research Site, Johannesburg

2031

Research Site, Randwick

2193

Research Site, Parktown

3000

Research Site, Leuven

3052

Research Site, Parkville

4000

Research Site, Liège

4001

Research Site, Durban

4032

Research Site, Debrecen

4056

Research Site, Basel

4101

Research Site, South Brisbane

6720

Research Site, Szeged

7505

Research Site, Tygerberg

8032

Research Site, Zurich

9000

Research Site, Ghent

9006

Research Site, Sankt Gallen

10021

Research Site, New York

15224

Research Site, Pittsburgh

28009

Research Site, Madrid

28046

Research Site, Madrid

30322

Research Site, Atlanta

31096

Research Site, Haifa

34295

Research Site, Montpellier

35100

Research Site, Izmir

37232

Research Site, Nashville

43205

Research Site, Columbus

45229

Research Site, Cincinnati

46026

Research Site, Valencia

46260

Research Site, Indianapolis

49202

Research Site, Petach Tikvah

52242

Research Site, Iowa City

52621

Research Site, Tel Litwinsky

54511

Research Site, Vandœuvre-lès-Nancy

60611

Research Site, Chicago

61615

Research Site, Peoria

64108

Research Site, Kansas City

64239

Research Site, Tel Aviv

64460

Research Site, Monterrey

75019

Research Site, Paris

75390

Research Site, Dallas

76104

Research Site, Fort Worth

77030

Research Site, Houston

84101

Research Site, Beersheba

89109

Research Site, Las Vegas

91120

Research Site, Jerusalem

95661

Research Site, Roseville

117198

Research Site, Moscow

117997

Research Site, Moscow

197022

Research Site, Saint Petersburg

350007

Research Site, Krasnodar

400138

Research Site, Volgograd

410028

Research Site, Saratov

66033-000

Research Site, Belém

17210-120

Research Site, Jaú

05403-000

Research Site, São Paulo

08270-070

Research Site, São Paulo

L8S 4K1

Research Site, Hamilton

M5G 1X8

Research Site, Toronto

H3T 1C5

Research Site, Montreal

H4A 3J1

Research Site, Montreal

775 20

Research Site, Olomouc

708 52

Research Site, Ostrava-Poruba

150 06

Research Site, Prague

06202

Research Site, Nice

85-094

Research Site, Bydgoszcz

91-738

Research Site, Lodz

10-561

Research Site, Olsztyn

41-800

Research Site, Zabrze

08035

Research Site, Barcelona

08950

Research Site, Esplugues de Llobregat

01130

Research Site, Adana

07059

Research Site, Antalya

B4 6NH

Research Site, Birmingham

EH9 1LF

Research Site, Edinburgh

W12 0HS

Research Site, London

M13 9WL

Research Site, Manchester

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Amgen

INDUSTRY